StockNews.com Initiates Coverage on Applied DNA Sciences (NASDAQ:APDN)

Investment analysts at StockNews.com began coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a note issued to investors on Thursday. The firm set a “hold” rating on the technology company’s stock.

Separately, HC Wainwright increased their target price on shares of Applied DNA Sciences from $1.50 to $7.00 and gave the stock a “buy” rating in a research note on Monday, May 13th.

Applied DNA Sciences Stock Performance

Shares of APDN opened at $1.99 on Thursday. Applied DNA Sciences has a 52-week low of $1.65 and a 52-week high of $37.20. The stock’s 50-day simple moving average is $5.89 and its 200 day simple moving average is $10.93. The stock has a market capitalization of $1.95 million, a price-to-earnings ratio of -0.12 and a beta of 0.26.

Hedge Funds Weigh In On Applied DNA Sciences

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC acquired a new position in Applied DNA Sciences, Inc. (NASDAQ:APDN) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned about 0.72% of Applied DNA Sciences at the end of the most recent quarter. 22.22% of the stock is owned by institutional investors.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.